EO-14407
Realigning United States Core Childhood Vaccine Recommendations With Best Practices From Peer, Developed Countries
- Signed
- May 29, 2026
- Published
- Jun 3, 2026
Federal Register: 2026-11180
Source: Federal Register.
Directing Review of U.S. Childhood Vaccine Schedule
Impact7/10
What it does
This order directs the CDC and its Advisory Committee on Immunization Practices (ACIP) to review the U.S. childhood and adolescent vaccine schedule using a government-commissioned scientific assessment that compared U.S. recommendations to those of peer developed nations. It instructs federal agencies to align their immunization-related funding, coverage, and regulations with whatever updated schedule ACIP and CDC adopt, while maintaining insurance and Medicaid coverage for all vaccines on the schedule. It also directs HHS to share the scientific assessment with state governments as an informational resource.
Who benefits
Parents who prefer greater flexibility in vaccine timing and sequencing for their children. Families with religious objections to certain vaccines, who may see fewer mandated doses. Pediatricians and family doctors who favor individualized immunization schedules. Children in households where parents have declined some vaccines due to concerns about the current schedule's breadth. State governments that have sought more latitude in setting their own vaccination policies.
Who is affected
Children who may lose access to vaccines removed from the "core" schedule if coverage or availability changes in practice. Public health officials and epidemiologists who rely on the current broad schedule to maintain herd immunity thresholds. Vaccine manufacturers whose products could be deprioritized if the schedule is narrowed. School districts and childcare facilities that use the federal schedule as the basis for enrollment requirements. Low-income families enrolled in Medicaid, CHIP, or the Vaccines for Children Program, whose covered vaccines would shift with any schedule changes. Children with immunocompromising conditions who depend on high community vaccination rates for protection.
Supporters argue
Supporters argue that the U.S. recommends significantly more childhood vaccine doses than comparable wealthy nations — in some cases more than twice as many — and that aligning with international consensus would produce a schedule grounded in the broadest cross-national scientific agreement. They contend that peer nations achieve high vaccination rates through education and public trust rather than mandates, suggesting that a more flexible, parent-centered approach could actually improve uptake by reducing resistance. Supporters also argue that the order preserves access to all currently available vaccines and maintains existing coverage requirements, meaning no child loses access — it simply opens a formal, evidence-based review process.
Opponents argue
Opponents argue that the U.S. schedule reflects domestic epidemiological conditions, disease prevalence, and population risk factors that differ meaningfully from European peer nations, making direct comparisons misleading as a basis for reducing recommendations. They contend that framing the current schedule as an outlier — rather than a response to specific U.S. public health needs — could erode public confidence in vaccines and contribute to declining vaccination rates, potentially triggering outbreaks of preventable diseases. Opponents also argue that directing ACIP's review toward a predetermined international benchmark risks politicizing what has historically been an independent, evidence-driven scientific process.
Constitutional basis
Executive orders rest on constitutional authority or statutory delegation. This summary describes the legal grounding cited or implied by the order.
The order invokes the President's general Article II executive authority to direct executive branch agencies, including HHS and CDC, in carrying out their statutory functions. The order's coverage mandates reference statutory programs — Medicaid (Title XIX of the Social Security Act), CHIP (Title XXI), and the Vaccines for Children Program (42 U.S.C. § 1396s) — which provide the underlying spending authority. Because the order directs agency review and policy alignment rather than creating new law, it operates within existing statutory delegations to HHS and does not independently create or eliminate coverage obligations.